A comparison of region-of-interest measures for extracting whole brain data using survival analysis in alcoholism as an example

J Neurosci Methods. 2015 Mar 15:242:58-64. doi: 10.1016/j.jneumeth.2015.01.001. Epub 2015 Jan 12.

Abstract

Background: Aggregation of functional magnetic resonance imaging (fMRI) data in regions-of-interest (ROIs) is required for complex statistical analyses not implemented in standard fMRI software. Different data-aggregation measures assess various aspects of neural activation, including spatial extent and intensity.

New method: In this study, conducted within the framework of the PREDICT study, we compared different aggregation measures for voxel-wise fMRI activations to be used as prognostic factors for relapse in 49 abstinent alcohol-dependent individuals in an outpatient setting using a cue-reactivity task. We compared the importance of the data-aggregation measures as prognostic factors for treatment outcomes by calculating the proportion of explained variation.

Results and comparison with existing method(s): Relapse risk was associated with cue-induced brain activation during abstinence in the ventral striatum (VS) and in the orbitofrontal cortex (OFC). While various ROI measures proved appropriate for using fMRI cue-reactivity to predict relapse, on the descriptive level the most "important" prognostic factor was a measure defined as the sum of t-values exceeding an individually defined threshold. Data collected in the VS was superior to that from other regions.

Conclusions: In conclusion, it seems that fMRI cue-reactivity, especially in the VS, can be used as prognostic factor for relapse in abstinent alcohol-dependent patients. Our findings suggest that data-aggregation measures that take both spatial extent and intensity of cue-induced brain activation into account make better biomarkers for predicting relapse than measures that consider an activation's spatial extent or intensity alone.

Trial registration: ClinicalTrials.gov NCT00317031.

Keywords: Addiction; Prognostic factor; Region of interest; Relapse; Survival analysis; fMRI.

Publication types

  • Clinical Trial
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Alcoholism / diagnosis*
  • Alcoholism / physiopathology*
  • Alcoholism / therapy
  • Brain / physiopathology*
  • Brain Mapping / methods
  • Cues
  • Female
  • Follow-Up Studies
  • Humans
  • Magnetic Resonance Imaging / methods*
  • Male
  • Middle Aged
  • Neuropsychological Tests
  • Outpatients
  • Prognosis
  • Recurrence
  • Risk
  • Signal Processing, Computer-Assisted
  • Survival Analysis
  • Treatment Outcome
  • Visual Perception / physiology

Associated data

  • ClinicalTrials.gov/NCT00317031